Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTaylor Wimpey Regulatory News (TW.)

Share Price Information for Taylor Wimpey (TW.)

Share Price is delayed by 15 minutes
Get Live Data
83.84    -0.74 (-0.87%)
Bid:
83.94
Ask:
84.16
Spread: 0.22 (0.262%)
Market Cap: £2.91b
TW. Live PriceLast checked at - London Stock Exchange

Intraday Taylor Wimpey Share Chart

Trading Statement

23 Apr 2024 07:00

RNS Number : 5884L
Taylor Wimpey PLC
23 April 2024
 

23 April 2024

Taylor Wimpey plc

Trading statement for the period covering 1 January 2024 to today

 

Spring selling season progressing as expected, full year 2024 guidance reiterated

Taylor Wimpey plc is holding its Annual General Meeting (AGM) today at 10:30am at the Crowne Plaza Hotel in Gerrards Cross, where the following comments will be made regarding current trading, financial performance, and outlook for the financial year.

Jennie Daly, Chief Executive commented:

"We have made a good start to 2024 with the Spring selling season progressing as expected. While we are mindful of ongoing market uncertainty and affordability challenges, it is pleasing to see continued market stability supported by good mortgage availability and sustained customer confidence. Our teams are working hard on the ground to support our customers through the buying process, underpinned by our strong marketing strategy and the quality and location of our homes, which are driving good levels of interest.

Looking ahead, we are confident that we have a strong and resilient business supported by a high-quality, well-located landbank. We remain focused on driving value and investing in the long term sustainability of the business, and we remain on track to deliver our guidance for 2024 while ensuring we are positioned for growth from 2025, assuming supportive market conditions."

UK current trading

The Spring selling season is progressing in line with our expectations. Traffic to our website is encouraging and there are good levels of visitors to our sites despite some market uncertainty and affordability challenges for some customers. Lenders continue to be supportive and mortgage rates remain competitive and below last year's highs, with good product availability.

Our net private sales rate for the year to 21 April 2024 was 0.73 per outlet per week (2023: 0.75), with a cancellation rate of 13% (2023: 15%). Excluding bulk sales, our net private sales rate for the year to 21 April 2024 was 0.69 per outlet per week (2023: 0.66).

As at 21 April 2024, our total order book value stood at £2,090 million (2023: £2,379 million) representing 7,686 homes (2023: 8,576 homes).

High-quality landbank

We are differentiated by our high-quality, well-located landbank, which is supported by a strong strategic land pipeline, providing additional optionality through the cycle. We continue to focus on the conversion of plots from our strategic pipeline and successfully converted c.1.5k plots into our short term landbank in the period. We remain selective in our approach to new acquisitions but will be active where we see opportunities that balance risk, reward and returns to create shareholder value. In the year to date we have approved c.1.4k new plots. At the end of March 2024, our short term landbank stood at c.81k plots (2023: c.86k plots), with a further c.140k potential plots (2023: c.140k plots) in our strategic pipeline.

Dividend

As previously announced, we intend to pay a 2023 final ordinary dividend of 4.79 pence per share on 10 May 2024 (2022 final dividend: 4.78 pence per share), subject to shareholder approval at today's AGM. This is in line with our Ordinary Dividend Policy to return c.7.5% of net assets annually, in two equal instalments.

Outlook

We remain focused on prioritising value over volume, building a strong order book and positioning ourselves for growth from 2025, assuming supportive market conditions.

We continue to expect 2024 UK completions (excluding JVs) to be in the range of 9,500 to 10,000, with completions weighted 45% / 55% in favour of the second half of the year. As previously guided, first half operating profit margin* will reflect slightly lower pricing in the order book and build cost inflation embedded in work in progress of around 4%.

Looking ahead, we remain well positioned in an attractive market with significant unmet demand. Our strong landbank and clear strategy enable us to build high-quality homes, create thriving communities and drive value for our stakeholders through the cycle and into the long term.

 

* Operating profit is defined as profit on ordinary activities before financing, exceptional items and tax, after share of results of joint ventures. Operating profit margin is defined as operating profit divided by revenue.

 

Note:

2023 relates to the equivalent trading period, unless stated

 

-Ends-

 

CEO Jennie Daly and Group Finance Director Chris Carney will be hosting a conference call with Q&A for analysts and investors at 8:30am on 23 April 2024. The call will be recorded and streamed live to our website: www.taylorwimpey.co.uk/corporate/investors/results-and-reports

 

For further information please contact:

Taylor Wimpey plc Tel: +44 (0) 1494 885656

 

Jennie Daly, CEO

Chris Carney, Group Finance Director

Debbie Archibald, Investor Relations

Andrew McGeary, Investor Relations

 

FGS Global TaylorWimpey@fgsglobal.com

Faeth Birch

Anjali Unnikrishnan

James Gray

Notes to editors:

 

Taylor Wimpey plc is a customer-focused homebuilder operating at a local level from 22 regional businesses across the UK. We also have operations in Spain. Our purpose is to deliver great homes and create thriving communities.

 

For further information, please visit the Group's website: www.taylorwimpey.co.uk/corporate

 

Follow our company page on LinkedIn, Taylor Wimpey plc

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFIASFIFFIS
Date   Source Headline
17th Mar 20223:13 pmRNSHolding(s) in Company
17th Mar 20227:00 amRNSTransaction in Own Shares
16th Mar 20227:00 amRNSTransaction in Own Shares
15th Mar 20227:00 amRNSTransaction in Own Shares
14th Mar 20227:00 amRNSTransaction in Own Shares
11th Mar 20227:00 amRNSTransaction in Own Shares
10th Mar 20223:55 pmRNSDirector/PDMR Shareholding
10th Mar 20227:00 amRNSTransaction in Own Shares
9th Mar 20224:21 pmRNSDirector/PDMR Shareholding
9th Mar 20224:17 pmRNSHolding(s) in Company
9th Mar 20227:00 amRNSTransaction in Own Shares
8th Mar 20227:00 amRNSTransaction in Own Shares
7th Mar 20227:00 amRNSTransaction in Own Shares
4th Mar 202210:44 amRNSDirector/PDMR Shareholding
4th Mar 20227:00 amRNSTransaction in Own Shares
3rd Mar 20227:01 amRNSShare Buyback Programme
3rd Mar 20227:00 amRNSAnnual Financial Report
1st Mar 20224:09 pmRNSTotal Voting Rights
24th Feb 20227:21 amRNSDirector Declaration
9th Feb 20222:20 pmRNSDirector/PDMR Shareholding
7th Feb 20227:00 amRNSCEO appointment
1st Feb 202211:02 amRNSTotal Voting Rights
31st Jan 20227:00 amRNSBoard and Board Committee changes
17th Jan 20227:00 amRNSTrading Statement
13th Jan 202211:21 amRNSHolding(s) in Company
11th Jan 20224:42 pmRNSDirector/PDMR Shareholding
4th Jan 20223:47 pmRNSTotal Voting Rights
4th Jan 20223:47 pmRNSBlock listing Interim Review
4th Jan 20223:46 pmRNSBlock listing Interim Review
22nd Dec 202111:35 amRNSDirector/PDMR Shareholding
22nd Dec 20217:05 amRNSAgreement of voluntary undertakings with the CMA
13th Dec 20214:16 pmRNSDirector/PDMR Shareholding
9th Dec 20212:57 pmRNSDirector/PDMR Shareholding
8th Dec 20217:00 amRNSUpcoming Board change
1st Dec 20213:00 pmRNSTotal Voting Rights
17th Nov 20214:31 pmRNSDirector/PDMR Shareholding
17th Nov 20218:00 amRNSAdditional Listing
11th Nov 20217:00 amRNSTrading statement
9th Nov 20213:33 pmRNSDirector/PDMR Shareholding
3rd Nov 20214:07 pmRNSPurchase of Shares by Employee Benefit Trust
1st Nov 202110:45 amRNSTotal Voting Rights
11th Oct 20211:13 pmRNSDirector/PDMR Shareholding
7th Oct 20214:25 pmRNSDirector/PDMR Shareholding
6th Oct 20213:33 pmRNSDirector/PDMR Shareholding
1st Oct 202112:29 pmRNSTotal Voting Rights
1st Oct 202112:28 pmRNSDirector/PDMR Shareholding
9th Sep 202112:48 pmRNSDirector/PDMR Shareholding
1st Sep 202111:51 amRNSTotal Voting Rights
10th Aug 202111:41 amRNSDirector/PDMR Shareholding
4th Aug 20217:00 amRNSHalf year results 2021

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.